Immunocore Holdings Plc (IMCR)
30.62
+0.46
(+1.54%)
USD |
NASDAQ |
Apr 01, 14:34
Immunocore Holdings Profit Margin (Quarterly) : -28.77% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -2.68% |
| Haleon Plc | -- |
| Silence Therapeutics Plc | -34.62K% |
| Adaptimmune Therapeutics Plc | -221.8% |
| Biodexa Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.34% |
| Return on Assets | -3.36% |
| Return on Invested Capital | -4.36% |
| Gross Profit Margin (Quarterly) | 96.61% |
| Operating Margin (Quarterly) | -18.85% |
| Return on Net Operating Assets | -27.35% |